Dr. John Cush RheumNow
2 years 11 months ago
#ACRbest Abstracts – Day 2
Our reporters have been prolific in finding the hot abstracts, those that were most attended or those that are getting the most buzz on social media. Here are RheumNows #ACRbest abstract reports from Monday, 11/13 at #ACR23.
https://t.co/qc1PxBKmow https://t.co/leaXyuS2UF
Dr. John Cush RheumNow
2 years 11 months ago
Lupus Topic Panel
Featuring panelists Dr. Kathryn Dao, Eric Dein and Sheila Reyes, discussing the best and most interesting lupus studies presented at #ACR23.
https://t.co/4lZmEBH8or https://t.co/L1ZTNeMFWr
Dr. John Cush RheumNow
2 years 11 months ago
Methotrexate: shall we split up?
Methotrexate (MTX) is widely used in rheumatic diseases yet poses common tolerance issues, especially for the oral form; and bioavailability is known to be limited for doses over 15mg.
https://t.co/yxvI9Q0B9m https://t.co/MxPQ4DAGsj
Dr. John Cush RheumNow
2 years 11 months ago
Maintain Vigilance for CV Risk Postpartum in Autoimmune Diseases
Pregnant women with ARDs and APS face significantly increased risks of CVEs. This increased risk is often attributed to ARDs, its medications or comorbidities associated with it.
https://t.co/A2Keo8fH4p https://t.co/oHIYNNlzUU
Dr. John Cush RheumNow
2 years 11 months ago
#ACR23 BEST Abstracts from San Diego – Day 1
From hundreds of online presentations, the poster floor and the plenary podium, here are some of the best abstracts from 11/12/23. You can spot these on Twitter by looking for the (#ACRbest) hashtag.
https://t.co/hmSNMFuwAY https://t.co/1X89oE8Iet
Dr. John Cush RheumNow
2 years 11 months ago
Will CAR T Cells also treat RA?
Dr. Jonathan Kay reports on abstract 0424 from #ACR23.
https://t.co/shb8tpDut4 https://t.co/xLn36Yg9fn
Dr. John Cush RheumNow
2 years 11 months ago
RHEUM Survey Question: Your choice of a biologic in patients with SpA is mostly influenced by? Click here to answer: https://t.co/zevKhcDPjz
Dr. John Cush RheumNow
2 years 11 months ago
Watch: Ultrasound for PsA Stratification: Are We There Yet?
Dr. Aurelie Najm reports live from #ACR23
https://t.co/TeeBHl2LlU https://t.co/ObFtaJsTWp
Dr. John Cush RheumNow
2 years 11 months ago
New Biomarkers and Therapeutics Show Potential in Still's Disease
AOSD is a rare complex, sporadic, systemic autoinflammatory disease similar to sJIA characterized by sustained fever, salmon-colored rash, and arthritis
https://t.co/cGBBHsBdK7 https://t.co/a0EwBiTJSu
Dr. John Cush RheumNow
2 years 11 months ago
Urinary biomarkers precede loss of kidney function for lupus nephritis
In Abstract 0850, Dr. Andrea Fava from Johns Hopkins presents research on the value of urinary biomarkers as measure of intrarenal inflammation.
https://t.co/MJb9F3uEgr https://t.co/oXvNLelE89
Dr. John Cush RheumNow
2 years 11 months ago
Less (Glucocorticoids) is More in Lupus Nephritis
Dr. Yuz Yusof talks with Dr. Amir Saxena about abstract 0781 at the 2023 ACR Convergence meeting in San Diego, CA.
https://t.co/EriaJvBPj9 https://t.co/x5hNIAgBz2
Dr. John Cush RheumNow
2 years 11 months ago
Difficult toTreat PsA: Mainly Difficult to Define!
Dr. Aurelie Najm reports on abstract 0777 from the 2023 ACR Convergence meeting in San Diego, CA.
https://t.co/vXDY47xWfS https://t.co/l5hJFc7blH
Dr. John Cush RheumNow
2 years 11 months ago
Psoriatic Arthritis Topic Panel
https://t.co/I3puVr5HWa https://t.co/sCzjnnDG1G
Dr. John Cush RheumNow
2 years 11 months ago
Day 2 Report - ACR Plenaries: Changing the Practice of Rheumatology
The top ACR2023 Plenary abstracts Dr. Dao ( @kdao2011) found impactful for her practice were...
https://t.co/aXut7l7b79 https://t.co/ATO5r5OzGK
Chronic low back pain is a common complaint that brings patients to the doctor’s attention. Although the majority of low back pain is mechanical in nature, an important minority is inflammatory in nature. Therefore, prompt referral to a rheumatologist is warranted particularly in the presence of other features suggestive of axial spondyloarthritis (axSpA).
